ACR Appropriateness Criteria® Ductal Carcinoma in Situ
June 15, 2015BySeth A. Kaufman, MD|Eleanor E. R. Harris, MD|Lisa Bailey, MD|Manjeet Chadha, MD|Sharon C. Dutton, MD|Gary M. Freedman, MD|Sharad Goyal, MD|Michele Y. Halyard, MD|Kathleen C. Horst, MD|Kristina L. M. Novick, MD|Catherine C. Park, MD|W. Warren Suh, MD|Deborah Toppmeyer, MD|Jennifer Zook, MD|Bruce G. Haffty, MD
Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.